Get a glimpse into our company and investor data—powered by the PitchBook Platform
Owner and operator of is a late-stage biopharmaceutical company. The company focuses on the development of neurological drugs that target inflammatory diseases of the peripheral nerves.
This information is reserved for PitchBook Platform users. To explore Neurorecovery‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.